Arthur L. Shaffer

Active 1996–2024

50
Papers
20,222
Citations
47
h-index
50
i10-index

Citations

Citations per year for Arthur L. Shaffer1982: 1 citations1988: 2 citations1993: 1 citations1994: 1 citations1996: 4 citations1997: 15 citations1998: 37 citations1999: 31 citations2000: 52 citations2001: 32 citations2002: 83 citations2003: 102 citations2004: 90 citations2005: 111 citations2006: 149 citations2007: 149 citations2008: 117 citations2009: 150 citations2010: 208 citations2011: 226 citations2012: 285 citations2013: 271 citations2014: 309 citations2015: 294 citations2016: 240 citations2017: 178 citations2018: 230 citations2019: 787 citations2020: 761 citations2021: 742 citations2022: 541 citations2023: 421 citations2024: 623 citations2025: 244 citations2026: 4 citations1983–1987: no citations, so these years are not shown1989–1992: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,817 citing papers, 32.4% of this breakdownChina: 743 citing papers, 8.6% of this breakdownGermany: 581 citing papers, 6.7% of this breakdownUnited Kingdom: 540 citing papers, 6.2% of this breakdownFrance: 375 citing papers, 4.3% of this breakdownItaly: 372 citing papers, 4.3% of this breakdownCanada: 343 citing papers, 4% of this breakdownJapan: 311 citing papers, 3.6% of this breakdownSpain: 290 citing papers, 3.3% of this breakdownSwitzerland: 259 citing papers, 3% of this breakdownAustralia: 253 citing papers, 2.9% of this breakdownNetherlands: 186 citing papers, 2.1% of this breakdown
0%32.4%Other 18.6%

Fields

  • Medicine48.6%
  • Biochemistry, Genetics and Molecular Biology28.6%
  • Immunology and Microbiology21.2%
  • Neuroscience0.5%
  • Agricultural and Biological Sciences0.2%
  • Chemistry0.2%
  • Other0.7%

Topics

  • Lymphoma Diagnosis and Treatment10.7%
  • Immune Cell Function and Interaction7.5%
  • T-cell and B-cell Immunology5.5%
  • Chronic Lymphocytic Leukemia Research5.5%
  • CAR-T cell therapy research3.8%
  • Protein Degradation and Inhibitors2.9%
  • Other64.1%

Coauthors

All papers

Open in search
  1. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew D. Zelenetz, John P. Leonard, Nancy L. Bartlett, Bao Tran, Jyoti Shetty, Yongmei Zhao, Dan Soppet, Stefania Pittaluga, Wyndham H. Wilson, Louis M. Staudt - New England Journal of Medicine 2018 cited by 2,261

  2. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rita M. Braziel, Raymond R. Tubbs, James R. Cook, Dennis D. Weisenburger, Wing C. Chan, Susan K. Pierce, Louis M. Staudt - Nature 2010 cited by 1,663

  3. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 1,110

  4. Oncogenically active MYD88 mutations in human lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis M. Staudt - Nature 2010 cited by 1,518

  5. A multiprotein supercomplex controlling oncogenic signalling in lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa M. Rimsza, Fausto J. Rodríguez, Fayez Estephan, Matthias Holdhoff, Michael J. Kruhlak, Stephen M. Hewitt, Craig J. Thomas, Stefania Pittaluga, Thomas Oellerich, Louis M. Staudt - Nature 2018 cited by 403

  6. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rita M. Braziel, Raymond R. Tubbs, James R. Cook, Dennis D. Weisenburger, Wing C. Chan, Stefania Pittaluga, Wyndham H. Wilson, Thomas A. Waldmann, Martin Rowe, Sam M. Mbulaiteye, Alan B. Rickinson, Louis M. Staudt - Nature 2012 cited by 920

  7. IRF4 addiction in multiple myeloma

    Authors: , , , , , , , , , , , , , - Nature 2008 cited by 736

  8. XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation

    Authors: , , , , , , , , , , , , , , , , - Immunity 2004 cited by 1,040

  9. Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program

    Authors: , , , , , , , , , , - Immunity 2002 cited by 1,027

  10. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter J. McGuire, Stefania Pittaluga, Ronald N. Germain, Richard Apps, Daniella M. Schwartz, Kaitlyn Sadtler, Susan Moir, Daniel S. Chertow, Steven H. Kleinstein, Surender Khurana, John S. Tsang, Pamela Mudd, Pamela L. Schwartzberg, Kalpana Manthiram - Nature Immunology 2022 cited by 83

  11. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 985

  12. Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2012 cited by 514

  13. Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6

    Authors: , , , , - Science 1997 cited by 942

  14. Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis M. Staudt - Blood Cancer Discovery 2021 cited by 61

  15. Graded Expression of Interferon Regulatory Factor-4 Coordinates Isotype Switching with Plasma Cell Differentiation

    Authors: , , , , , - Immunity 2006 cited by 551

  16. Pathogenesis of Human B Cell Lymphomas

    Authors: , , - Annual Review of Immunology 2012 cited by 429

  17. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 114

  18. In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 45

  19. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 123

  20. B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma

    Authors: , , , - Seminars in Hematology 2015 cited by 216

  21. Rewiring of B cell receptor signaling by Epstein–Barr virus LMP2A

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 72

  22. Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ravshan Ataullakhanov, Nathan Fowler, Michael C. Kelly, Jagan Muppidi, Jeremy L. Davis, Jonathan M. Hernandez, Wyndham H. Wilson, Elaine S. Jaffe, Louis M. Staudt, Mark Roschewski, Ronald N. Germain - Cancer Cell 2024 cited by 62

  23. BCL-6 Represses Genes that Function in Lymphocyte Differentiation, Inflammation, and Cell Cycle Control

    Authors: , , , , , - Immunity 2000 cited by 867

  24. Dendritic cell fate is determined by BCL11A

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 133